(CHKP) Check Point Software - Overview
Stock: Network Security, Cloud Security, Endpoint Security, Threat Prevention
| Risk 5d forecast | |
|---|---|
| Volatility | 32.0% |
| Relative Tail Risk | -6.69% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.15 |
| Alpha | -49.58 |
| Character TTM | |
|---|---|
| Beta | 0.771 |
| Beta Downside | 0.512 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.87% |
| CAGR/Max DD | 0.21 |
EPS (Earnings per Share)
Revenue
Description: CHKP Check Point Software March 04, 2026
Check Point Software Technologies Ltd. (CHKP) develops and markets IT security products and services globally. The company offers a multi-level security architecture protecting cloud, network, mobile, endpoint, and IoT environments. This includes on-premises security solutions like AI-powered threat prevention for mesh networks and security gateways, as well as cloud security through its CloudGuard platform for unified, prevention-first cloud-native security. The cybersecurity sector is characterized by continuous innovation to combat evolving threats.
CHKP also provides workspace security via its Harmony platform, defending against attacks across email, web applications, devices, and remote access. Its Infinity platform services offer collaborative security operations, unified management, and AI-driven threat intelligence. The business model emphasizes recurring revenue from software subscriptions and managed services. The company further provides managed and professional cybersecurity services, technical support, and training.
For more in-depth analysis, consider exploring ValueRays comprehensive research.
Headlines to watch out for
- Subscription revenue growth drives financial performance
- Cloud security adoption impacts sales trajectory
- Cybersecurity spending trends influence enterprise demand
- Geopolitical events increase global cyber threats
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 1.06b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.16 > 0.02 and ΔFCF/TA -1.39 > 1.0 |
| NWC/Revenue: 74.39% < 20% (prev 9.72%; Δ 64.67% < -1%) |
| CFO/TA 0.17 > 3% & CFO 1.31b > Net Income 1.06b |
| Net Debt (172.1m) to EBITDA (981.2m): 0.18 < 3 |
| Current Ratio: 2.05 > 1.5 & < 3 |
| Outstanding Shares: last quarter (108.4m) vs 12m ago -3.30% < -2% |
| Gross Margin: 85.42% > 18% (prev 0.88%; Δ 8.45k % > 0.5%) |
| Asset Turnover: 40.19% > 50% (prev 44.57%; Δ -4.38% > 0%) |
| Interest Coverage Ratio: -15.64 > 6 (EBITDA TTM 981.2m / Interest Expense TTM -56.8m) |
Altman Z'' 10.00
| A: 0.26 (Total Current Assets 3.96b - Total Current Liabilities 1.94b) / Total Assets 7.81b |
| B: 1.93 (Retained Earnings 15.07b / Total Assets 7.81b) |
| C: 0.13 (EBIT TTM 888.3m / Avg Total Assets 6.78b) |
| D: 3.07 (Book Value of Equity 15.11b / Total Liabilities 4.92b) |
| Altman-Z'' Score: 12.10 = AAA |
Beneish M -3.12
| DSRI: 0.99 (Receivables 769.1m/728.8m, Revenue 2.73b/2.56b) |
| GMI: 1.02 (GM 85.42% / 87.55%) |
| AQI: 0.80 (AQ_t 0.48 / AQ_t-1 0.60) |
| SGI: 1.06 (Revenue 2.73b / 2.56b) |
| TATA: -0.03 (NI 1.06b - CFO 1.31b) / TA 7.81b) |
| Beneish M-Score: -3.12 (Cap -4..+1) = AA |
What is the price of CHKP shares?
Over the past week, the price has changed by -2.53%, over one month by -12.71%, over three months by -22.39% and over the past year by -30.73%.
Is CHKP a buy, sell or hold?
- StrongBuy: 11
- Buy: 5
- Hold: 22
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the CHKP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 203.3 | 32% |
| Analysts Target Price | 203.3 | 32% |
CHKP Fundamental Data Overview March 12, 2026
P/E Forward = 15.083
P/S = 6.4789
P/B = 5.8853
P/EG = 1.5091
Revenue TTM = 2.73b USD
EBIT TTM = 888.3m USD
EBITDA TTM = 981.2m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 1.97b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 172.1m USD (from netDebt column, last quarter)
Enterprise Value = 16.61b USD (17.66b + Debt 1.97b - CCE 3.01b)
Interest Coverage Ratio = -15.64 (Ebit TTM 888.3m / Interest Expense TTM -56.8m)
EV/FCF = 12.92x (Enterprise Value 16.61b / FCF TTM 1.29b)
FCF Yield = 7.74% (FCF TTM 1.29b / Enterprise Value 16.61b)
FCF Margin = 47.20% (FCF TTM 1.29b / Revenue TTM 2.73b)
Net Margin = 38.78% (Net Income TTM 1.06b / Revenue TTM 2.73b)
Gross Margin = 85.42% ((Revenue TTM 2.73b - Cost of Revenue TTM 397.4m) / Revenue TTM)
Gross Margin QoQ = 85.10% (prev 85.34%)
Tobins Q-Ratio = 2.13 (Enterprise Value 16.61b / Total Assets 7.81b)
Interest Expense / Debt = 0.12% (Interest Expense 2.30m / Debt 1.97b)
Taxrate = 21.0% (US default 21%)
NOPAT = 701.8m (EBIT 888.3m * (1 - 21.00%))
Current Ratio = 2.05 (Total Current Assets 3.96b / Total Current Liabilities 1.94b)
Debt / Equity = 0.68 (Debt 1.97b / totalStockholderEquity, last quarter 2.88b)
Debt / EBITDA = 0.18 (Net Debt 172.1m / EBITDA 981.2m)
Debt / FCF = 0.13 (Net Debt 172.1m / FCF TTM 1.29b)
Total Stockholder Equity = 2.89b (last 4 quarters mean from totalStockholderEquity)
RoA = 15.59% (Net Income 1.06b / Total Assets 7.81b)
RoE = 36.62% (Net Income TTM 1.06b / Total Stockholder Equity 2.89b)
RoCE = 15.13% (EBIT 888.3m / Capital Employed (Total Assets 7.81b - Current Liab 1.94b))
RoIC = 24.30% (NOPAT 701.8m / Invested Capital 2.89b)
WACC = 7.86% (E(17.66b)/V(19.63b) * Re(8.73%) + D(1.97b)/V(19.63b) * Rd(0.12%) * (1-Tc(0.21)))
Discount Rate = 8.73% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.02%
[DCF] Terminal Value 78.39% ; FCFF base≈1.18b ; Y1≈1.17b ; Y5≈1.20b
[DCF] Fair Price = 200.5 (EV 21.70b - Net Debt 172.1m = Equity 21.53b / Shares 107.4m; r=7.86% [WACC]; 5y FCF grow -2.34% → 2.90% )
EPS Correlation: 83.83 | EPS CAGR: 22.67% | SUE: 1.24 | # QB: 2
Revenue Correlation: 85.01 | Revenue CAGR: 8.81% | SUE: -1.25 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.54 | Chg7d=-0.001 | Chg30d=+0.016 | Revisions Net=+8 | Analysts=35
EPS current Year (2026-12-31): EPS=10.45 | Chg7d=-0.004 | Chg30d=-0.041 | Revisions Net=+0 | Growth EPS=-12.1% | Growth Revenue=+6.2%
EPS next Year (2027-12-31): EPS=11.53 | Chg7d=-0.003 | Chg30d=-0.166 | Revisions Net=+3 | Growth EPS=+10.4% | Growth Revenue=+6.0%
[Analyst] Revisions Ratio: +0.31 (17 Up / 9 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.6% (Discount Rate 8.7% - Earnings Yield 6.1%)
[Growth] Growth Spread = +3.5% (Analyst 6.1% - Implied 2.6%)